IRCT20201212049690N1已完成2 期
Evaluation of oral Hydroxy Choloroquine on treatment of Generalized Vitiligo Vulgaris
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 7 years 至 no limit（—）
- 性别
- All
入选标准
- •Involvement of at least 10% of body surface
- •At least one month has passed since the last treatment for the patient
- •Not receiving any other treatment
- •Not taking other drugs at the same time with immunomodulatory and immunosuppressive effects
- •Over 7 years old
- •Weight over 35 kg
- •Do not take drugs that interfere with hydroxychloroquine, such as Image result for artemether and Dapsone and Lumfanterin
排除标准
- •Glucose-6-phosphate dehydrogenase deficiency
- •Retinopathy
- •Acute gastrointestinal disorders
- •Myasthenia gravis
- •Renal failure
- •Sensitivity to antimalarial compounds
- •Hepatic failure
研究者
相似试验
进行中（未招募）
不适用
Efficacy of the treatment with hydroxychloroquine in non responders HIV-infected HAART-treated patients - NDHIV infection (immunological nonresponders).MedDRA version: 9.1Level: LLTClassification code 10008922EUCTR2009-012499-28-ITAZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE)40
尚未招募
3 期
Efficacy of hydroxychloroquine in graves disease in addition to antithyroid drugs.CTRI/2023/07/054894IPQA laboratories
进行中（未招募）
不适用
Evaluation of the efficacy of hydroxychloroquine in decreasing immune activation in asymptomatic HIV-infected patients (HCQ-01) - Hydroxychloroquine studyHIV infectionMedDRA version: 9.1Level: LLTClassification code 10020161Term: HIV infectionEUCTR2007-005057-36-GBMedical Research Council
已完成
不适用
HCQ-01 Trial: evaluation of the efficacy of hydroxychloroquine in decreasing immune activation in asymptomatic human immunodeficiency virus (HIV) infected patientsISRCTN30019040Medical Research Council Clinical Trials Unit (MRC CTU) (UK)90
招募中
3 期
Hydroxychloroquine in comparison with hydroxychloroquine + azithromycin in patients with covid-19COVID-19.U07.1 - COVID-19COVID-19IRCT20200428047228N2Quality Improvement of Intensive Care Research Center- Shahid Beheshti University40